Stay updated on Risdiplam in SMA Type 2/3: Clinical Trial
Sign up to get notified when there's something new on the Risdiplam in SMA Type 2/3: Clinical Trial page.

Latest updates to the Risdiplam in SMA Type 2/3: Clinical Trial page
- Check6 days agoChange DetectedThe record now presents details of the completed SUNFISH risdiplam study, including its design, eligibility criteria, locations, outcome measures, publications, and study documents.SummaryDifference87%

- Check13 days agoChange DetectedThe footer revision number changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check27 days agoChange DetectedA general NIH website-transition notice appears above the 403 error message. The site revision label changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check41 days agoChange DetectedThe footer now displays site revision v3.7.1 instead of v3.7.0 on the 403 Forbidden page.SummaryDifference0.2%

- Check55 days agoChange DetectedThe study page now displays a 403 Forbidden error (with a minimal header and a Home link) instead of the full study record content for NCT02908685. This indicates blocked access rather than the usual display of the study details.SummaryDifference20%

- Check62 days agoChange DetectedA new page revision label, v3.7.0, was added and the previous revision label, v3.6.6, was removed, indicating the page has been updated to a newer version.SummaryDifference0.0%

Stay in the know with updates to Risdiplam in SMA Type 2/3: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risdiplam in SMA Type 2/3: Clinical Trial page.